Hyper Corporation

Hyper Corporation EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is 3.65 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -3.39 % — a change of -207.44% (higher).

EBIT/Assets

3.65 %

YoY

-207.44%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Hyper Corporation is 2025 3.65 % . Operating Income to Assets Ratio (EBIT/Assets) of Hyper Corporation was 2024 -3.39 % . It decreases by -207.44% higher compared to the previous year.

The Hyper Corporation EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2016
-13.13 KRW
Jan 1, 2017
-43.89 KRW
Jan 1, 2018
-27.26 KRW
Jan 1, 2019
-11.10 KRW
Jan 1, 2020
-4.58 KRW
Jan 1, 2022
-23.26 KRW
Jan 1, 2023
-3.39 KRW
Jan 1, 2025
3.65 KRW
The Hyper Corporation EBIT/Assets history
YEAREBIT/AssetsYoY
3.65 %-207.44%
-3.39 %-85.40%
-23.26 %+407.27%
-4.58 %-58.71%
-11.10 %-59.27%
-27.26 %-37.89%
-43.89 %+234.36%
-13.13 %+237.03%
-3.89 %-64.93%
-11.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Operating Income to Assets Ratio (EBIT/Assets) of Hyper Corporation is 3.65 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Hyper Corporation changed from -3.39 % to 3.65 %, representing a -207.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Hyper Corporation with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hyper Corporation

All Key Metrics — Hyper Corporation